Press Release: Open PHACTS and Data2Discovery Announce Strategic Partnership to Collaborate


(PDF) Cambridge, UK – The Open PHACTS Foundation is pleased to formally announce our new Strategic Partnership with Data2Discovery Inc.

Data2Discovery (http://www.d2discovery.com/) has extensive experience in pharmaceutical semantic linked data, and partners with pharmaceutical companies to develop full-stack semantic and graph capabilities to tackle real scientific problems. The goals of this partnership will support and progress the Open PHACTS vision of creating a sustainable, open, interoperable information infrastructure for applied life science research and development, while advancing science for the public benefit through shared knowledge and data in life science and biomedical research.

With input from our Members and user community, this collaboration will enable the Open PHACTS Foundation to make considerable efforts to review and refresh the current technical architecture of the Open PHACTS Discovery Platform, data and linksets, API, and workflow tools including KNIME and Pipeline Pilot. We will be sharing regular updates in the coming months, and we encourage and welcome input and feedback from all members of the community on this exciting new phase for Open PHACTS.

“We are really excited about the potential of Open PHACTS and Data2Discovery’s combined domain expertise and talents. This collaboration will enable us not only to refresh our existing datasets, but to update and streamline processes to support further analysis of the data in the Open PHACTS Discovery Platform and beyond, allowing for new ways of combining public and private datasets.”

Nick Lynch, CTO, Open PHACTS Foundation

About

The Open PHACTS Foundation

The Open PHACTS Foundation is a not-for-profit membership organisation, established to ensure the sustainability of the Open PHACTS Discovery Platform and other outcomes of the Open PHACTS project. The Open PHACTS Discovery Platform was built to answer key scientific questions for applied life sciences research and development, and to meet the needs of drug discovery scientists. The data integrated by Open PHACTS currently contains over three billion triples, and the diversity and size of data sets are growing rapidly.

The Open PHACTS Foundation is a registered charity in the United Kingdom.

http://www.openphactsfoundation.org/